San Diego, CA, United States of America

Matthew Saunders

This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Renew Biopharma, Inc., Glycosensors and Diagnostics, LLC, University of Georgia Research Foundation Inc. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Saunders. Retrieved from https://idiyas.com/inventor/matthew-saunders-nc2pfiju

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Matthew Saunders

Introduction: Matthew Saunders is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Matthew Saunders holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Matthew has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Matthew has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Matthew Saunders continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning ideas into reality.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…